# AbCellera Biologics Inc.: filings

ABCL · Nasdaq · CIK 1703057 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/abcl.md) · [Financials](/companies/abcl/financials.md) · [Filings](/companies/abcl/filings.md) · [Insiders](/companies/abcl/insiders.md)

## Reports and events: 100 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 120, 8-K 62, 10-Q 17, 3 15, 424B3 11, SC 13G/A 10, CORRESP 7, 10-K 6, DEF 14A 6, DEFA14A 6, S-8 6, SC 13G 6, UPLOAD 6, 5 4, ARS 4, D 4, EFFECT 3, S-1/A 3, 424B5 2, 4/A 2, POS AM 2, S-1 2, S-3ASR 2, SCHEDULE 13G/A 2, SEC STAFF LETTER 2, 10-K/A 1, 3/A 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, S-1MEF 1, SC 13D 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 16:33 ET | [8-K](/filings/0001193125-26-349353.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-349353 |
| 2026-08-10 | 07:49 ET | [8-K](/filings/0001703057-26-000053.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-26-000053 |
| 2026-08-07 | 16:43 ET | [8-K](/filings/0001703057-26-000049.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001703057-26-000049 |
| 2026-08-05 | 16:28 ET | [10-Q](/filings/0001703057-26-000046.md) | Quarterly report, period 2026-06-30 | 0001703057-26-000046 |
| 2026-08-05 | 16:18 ET | [8-K](/filings/0001703057-26-000044.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-26-000044 |
| 2026-07-29 | 11:38 ET | [8-K](/filings/0001703057-26-000039.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001703057-26-000039 |
| 2026-07-06 | 14:53 ET | [8-K](/filings/0001703057-26-000037.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001703057-26-000037 |
| 2026-06-17 | 12:38 ET | [8-K](/filings/0001703057-26-000035.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001703057-26-000035 |
| 2026-06-12 | 12:12 ET | [8-K](/filings/0001703057-26-000033.md) | 5.07 Shareholder vote results | 0001703057-26-000033 |
| 2026-06-05 | 12:03 ET | [8-K](/filings/0001703057-26-000031.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001703057-26-000031 |
| 2026-05-11 | 16:18 ET | [10-Q](/filings/0001703057-26-000028.md) | Quarterly report, period 2026-03-31 | 0001703057-26-000028 |
| 2026-05-11 | 16:11 ET | [8-K](/filings/0001703057-26-000027.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-26-000027 |
| 2026-04-29 | 14:07 ET | [DEF 14A](/filings/0001703057-26-000020.md) | Proxy statement, period 2025-12-31 | 0001703057-26-000020 |
| 2026-02-24 | 16:38 ET | [10-K](/filings/0001703057-26-000012.md) | Annual report, period 2025-12-31 | 0001703057-26-000012 |
| 2026-02-24 | 16:15 ET | [8-K](/filings/0001703057-26-000010.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-26-000010 |
| 2026-01-14 | 17:09 ET | [8-K](/filings/0001703057-26-000003.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-26-000003 |
| 2025-12-18 | 14:43 ET | [8-K](/filings/0001703057-25-000034.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-25-000034 |
| 2025-11-28 | 14:20 ET | [8-K](/filings/0001703057-25-000032.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001703057-25-000032 |
| 2025-11-12 | 13:47 ET | [8-K](/filings/0001703057-25-000029.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001703057-25-000029 |
| 2025-11-06 | 16:27 ET | [10-Q](/filings/0001703057-25-000025.md) | Quarterly report, period 2025-09-30 | 0001703057-25-000025 |
| 2025-11-06 | 16:21 ET | [8-K](/filings/0001703057-25-000024.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-25-000024 |
| 2025-09-10 | 12:23 ET | [8-K](/filings/0001703057-25-000018.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001703057-25-000018 |
| 2025-08-07 | 16:36 ET | [10-Q](/filings/0001703057-25-000011.md) | Quarterly report, period 2025-06-30 | 0001703057-25-000011 |
| 2025-08-07 | 16:27 ET | [8-K](/filings/0001628280-25-038927.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-038927 |
| 2025-06-13 | 13:20 ET | [8-K](/filings/0001628280-25-031219.md) | 5.07 Shareholder vote results | 0001628280-25-031219 |
| 2025-05-30 | 13:46 ET | [8-K](/filings/0001628280-25-028529.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-028529 |
| 2025-05-14 | 17:15 ET | [8-K](/filings/0001628280-25-025573.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-025573 |
| 2025-05-13 | 14:33 ET | [8-K](/filings/0001628280-25-025006.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-025006 |
| 2025-05-08 | 16:21 ET | [10-Q](/filings/0001628280-25-023836.md) | Quarterly report, period 2025-03-31 | 0001628280-25-023836 |
| 2025-05-08 | 16:14 ET | [8-K](/filings/0001628280-25-023808.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-023808 |
| 2025-04-29 | 16:27 ET | [DEF 14A](/filings/0001628280-25-020703.md) | Proxy statement, period 2024-12-31 | 0001628280-25-020703 |
| 2025-02-27 | 16:24 ET | [10-K](/filings/0001628280-25-008689.md) | Annual report, period 2024-12-31 | 0001628280-25-008689 |
| 2025-02-27 | 16:11 ET | [8-K](/filings/0001628280-25-008650.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-008650 |
| 2025-02-18 | 11:56 ET | [8-K](/filings/0001628280-25-005983.md) | 8.01 Other events | 0001628280-25-005983 |
| 2024-11-04 | 16:34 ET | [10-Q](/filings/0001628280-24-045026.md) | Quarterly report, period 2024-09-30 | 0001628280-24-045026 |
| 2024-11-04 | 16:28 ET | [8-K](/filings/0001628280-24-045022.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-045022 |
| 2024-08-06 | 16:55 ET | [10-Q](/filings/0001628280-24-035248.md) | Quarterly report, period 2024-06-30 | 0001628280-24-035248 |
| 2024-08-06 | 16:26 ET | [8-K](/filings/0001628280-24-035229.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-035229 |
| 2024-06-13 | 16:53 ET | [8-K](/filings/0001628280-24-028097.md) | 5.07 Shareholder vote results | 0001628280-24-028097 |
| 2024-05-07 | 16:47 ET | [10-Q](/filings/0001628280-24-021159.md) | Quarterly report, period 2024-03-31 | 0001628280-24-021159 |
| 2024-05-07 | 16:22 ET | [8-K](/filings/0001628280-24-021115.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-021115 |
| 2024-04-29 | 16:30 ET | [DEF 14A](/filings/0001628280-24-019019.md) | Proxy statement, period 2023-12-31 | 0001628280-24-019019 |
| 2024-02-23 | 16:49 ET | [8-K](/filings/0001703057-24-000024.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001703057-24-000024 |
| 2024-02-20 | 16:36 ET | [10-K](/filings/0001703057-24-000019.md) | Annual report, period 2023-12-31 | 0001703057-24-000019 |
| 2024-02-20 | 16:27 ET | [8-K](/filings/0001703057-24-000017.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-24-000017 |
| 2023-11-28 | 17:28 ET | [8-K](/filings/0001703057-23-000047.md) | 8.01 Other events | 0001703057-23-000047 |
| 2023-11-02 | 16:27 ET | [10-Q](/filings/0001703057-23-000040.md) | Quarterly report, period 2023-09-30 | 0001703057-23-000040 |
| 2023-11-02 | 16:13 ET | [8-K](/filings/0001703057-23-000038.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001703057-23-000038 |
| 2023-10-13 | 20:03 ET | [8-K](/filings/0001703057-23-000034.md) | 8.01 Other events | 0001703057-23-000034 |
| 2023-08-03 | 16:33 ET | [10-Q](/filings/0001703057-23-000022.md) | Quarterly report, period 2023-06-30 | 0001703057-23-000022 |

Page 1 of 2. [Older](/companies/abcl/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.